Accipiter Biosciences: Valuation, Funding & Investors
Accipiter Biosciences is a Seattle-based biotechnology company pioneering the design of de novo biologics for complex diseases. By leveraging advanced computational methods, the company creates multifunctional proteins that integrate multiple mechanisms in a single molecule, with the goal of delivering safer, more effective, and more convenient therapies for patients.
Leadership & Board
- Current Number of Employees
- 26
- Current LinkedIn Followers
- 1,862
Latest Estimated Valuation
- Total Amount Raised
- $13M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $13M
- Latest Funding Round
- Seed Round
Employee Trend
Accipiter Biosciences had 26 employees as of November 2, 2026. The number of employees increased by 0 (0.00%) week-over-week.
26Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Accipiter Biosciences had 1,862 followers as of November 2, 2026. The number of followers increased by 24 (1.31%) week-over-week.
1,862Latest Followers Count
24(1.31%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Nov 06, 2025 | Seed Round | $12.70M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Columbus Venture Partners | Seed Round |
| Takeda | Seed Round |
| Flying Fish Partners | Seed Round |
| Cercano Capital | Seed Round |
| Washington Research Foundation | Seed Round |
| Alexandria Investments | Seed Round |
| Pack Ventures | Seed Round |
| Argonautic Ventures | Seed Round |
Similar Companies
A snapshot of private companies similar to Accipiter Biosciences, helping you discover and navigate related company profiles.
Related News and Analysis
